- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x 01: (1S,3S)-N-[6-bromo-5-(pyrimidin-2-yl)pyridin-2-yl]-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxamide
01.1: 23 residues within 4Å:- Chain A: A.396, V.399, M.400, T.453, I.454, G.457, Y.458, L.460, F.461, I.492, A.495, V.496, L.499, A.578, I.579, V.581, G.582, G.583, L.586
- Chain B: F.461, L.465, I.579
- Ligands: 02.2
8 PLIP interactions:5 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:T.453, A:Y.458, A:A.495, A:I.579, B:F.461, B:F.461, B:L.465
- Hydrogen bonds: A:G.582
01.4: 22 residues within 4Å:- Chain A: F.461, L.465
- Chain B: A.396, V.399, M.400, T.453, I.454, G.457, Y.458, L.460, F.461, I.492, A.495, V.496, L.499, A.578, I.579, V.581, G.582, G.583, L.586
- Ligands: 02.5
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:T.453, B:A.495, B:V.496, A:F.461, A:F.461
- 2 x 02: [(2~{R})-3-[[(2~{R})-2,3-bis(oxidanyl)propoxy]-oxidanyl-phosphoryl]oxy-2-hexadecanoyloxy-propyl] octadecanoate
02.2: 48 residues within 4Å:- Chain A: Q.142, T.150, I.153, V.154, L.243, F.263, A.264, T.267, A.268, S.271, V.272, L.275, I.393, A.396, G.397, M.400, L.403, T.404, V.405, C.406, I.407, G.408, Y.410, V.411, Q.412, F.426, F.429, M.433, L.460, A.463, M.464, G.467, M.471, L.481, P.484, I.485, G.488, I.492, V.496, L.499, T.500, A.519, L.520, Q.523, Y.567, T.568, L.571
- Ligands: 01.1
16 PLIP interactions:16 interactions with chain A- Hydrophobic interactions: A:L.243, A:T.267, A:I.393, A:L.403, A:T.404, A:I.407, A:I.407, A:Y.410, A:F.429, A:L.520, A:Q.523, A:L.571, A:L.571
- Hydrogen bonds: A:S.271, A:S.271, A:Q.412
02.5: 48 residues within 4Å:- Chain B: Q.142, T.150, I.153, V.154, L.243, F.263, A.264, T.267, A.268, S.271, V.272, L.275, I.393, A.396, M.400, L.403, T.404, V.405, C.406, I.407, G.408, Y.410, V.411, Q.412, F.426, F.429, M.433, L.460, A.463, M.464, G.467, M.471, L.481, P.484, I.485, G.488, G.489, I.492, V.496, L.499, T.500, A.519, L.520, Q.523, Y.567, T.568, L.571
- Ligands: 01.4
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:A.268, B:I.393, B:L.403, B:T.404, B:Y.410, B:F.429, B:F.429, B:L.481, B:P.484, B:L.571
- 2 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Khandelwal, N.K. et al., Inhibitor BRD-8000.3 bound EfpA transporter of Mycobacterium tuberculosis. To Be Published
- Release Date
- 2025-02-05
- Peptides
- Uncharacterized MFS-type transporter EfpA: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x 01: (1S,3S)-N-[6-bromo-5-(pyrimidin-2-yl)pyridin-2-yl]-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxamide
- 2 x 02: [(2~{R})-3-[[(2~{R})-2,3-bis(oxidanyl)propoxy]-oxidanyl-phosphoryl]oxy-2-hexadecanoyloxy-propyl] octadecanoate
- 2 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Khandelwal, N.K. et al., Inhibitor BRD-8000.3 bound EfpA transporter of Mycobacterium tuberculosis. To Be Published
- Release Date
- 2025-02-05
- Peptides
- Uncharacterized MFS-type transporter EfpA: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.